BIOTON S.A. (WSE:BIO)

Poland flag Poland · Delayed Price · Currency is PLN
4.190
+0.040 (0.96%)
May 6, 2026, 5:00 PM CET
Market Cap359.77M +15.1%
Revenue (ttm)282.52M +36.0%
Net Income3.39M
EPS0.04
Shares Out85.86M
PE Ratio106.08
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume37,322
Average Volume16,733
Open4.175
Previous Close4.150
Day's Range4.100 - 4.200
52-Week Range3.650 - 4.700
Beta0.16
RSI51.26
Earnings DateApr 29, 2026

About BIOTON

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 364
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

Financial Statements